These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2109002)

  • 21. Effects of salbutamol on bronchoconstriction, bronchial hyperresponsiveness, and leucocyte responses induced by platelet activating factor in man.
    Chung KF; Dent G; Barnes PJ
    Thorax; 1989 Feb; 44(2):102-7. PubMed ID: 2648645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of a PAF antagonist, BN52063, on PAF-induced bronchoconstriction in normal subjects.
    Roberts NM; McCusker M; Chung KF; Barnes PJ
    Br J Clin Pharmacol; 1988 Jul; 26(1):65-72. PubMed ID: 3203062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
    Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
    J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cardiovascular and platelet actions of 9 beta-methyl carbacyclin (ciprostene), a chemically stable analogue of prostacyclin, in the dog and monkey.
    Allan G; Follenfant MJ; Lidbury P; Oliver PL; Whittle BJ
    Br J Pharmacol; 1985 Jun; 85(2):547-55. PubMed ID: 3896365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Failure of salmeterol to inhibit circulating white cell responses and bronchoconstriction induced by platelet activating factor.
    Spring J; Johnston SR; Seale J; Ind PW
    Thorax; 1992 Nov; 47(11):948-51. PubMed ID: 1361250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of dipyridamole alone and in combination with aspirin on whole blood platelet aggregation, PGI2 generation, and red cell deformability ex vivo in man.
    Saniabadi AR; Fisher TC; McLaren M; Belch JF; Forbes CD
    Cardiovasc Res; 1991 Mar; 25(3):177-83. PubMed ID: 2029709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultrastructural evidence for extravascular platelet recruitment in the lung upon intravenous injection of platelet-activating factor (PAF-acether) to guinea-pigs.
    Lellouch-Tubiana A; Lefort J; Pirotzky E; Vargaftig BB; Pfister A
    Br J Exp Pathol; 1985 Jun; 66(3):345-55. PubMed ID: 3890915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man.
    Cuss FM; Dixon CM; Barnes PJ
    Lancet; 1986 Jul; 2(8500):189-92. PubMed ID: 2873440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemodynamic effects of intravenous prostacyclin in stable angina pectoris.
    Firth BG; Winniford MD; Campbell WB; Hillis LD
    Am J Cardiol; 1983 Sep; 52(5):439-43. PubMed ID: 6351580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single-blind study of epoprostenol and 6-keto-prostaglandin E1 in man: effects of platelet aggregation and plasma renin.
    Miyamori I; Morise T; Yasuhara S; Takeda Y; Koshida H; Takeda R
    Br J Clin Pharmacol; 1985 Dec; 20(6):681-3. PubMed ID: 3912001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
    Krishnamurthi S; Westwick J; Kakkar VV
    Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet-activating factor impairs mucociliary transport and increases plasma leukotriene B4 in man.
    Nieminen MM; Moilanen EK; Nyholm J-E ; Koskinen MO; Karvonen JI; Metsä-Ketelä TJ; Vapaatalo H
    Eur Respir J; 1991 May; 4(5):551-60. PubMed ID: 1657632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of inhaled aerosol of platelet activating factor on pulmonary function and airway responsiveness in normal subjects].
    Li Q
    Zhonghua Jie He He Hu Xi Za Zhi; 1992 Aug; 15(4):222-4, 255. PubMed ID: 1307517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet activating factor does not cause a reproducible increase in bronchial responsiveness in normal man.
    Spencer DA; Green SE; Evans JM; Piper PJ; Costello JF
    Clin Exp Allergy; 1990 Sep; 20(5):525-32. PubMed ID: 2253083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of prostacyclin on pulmonary vascular response to thrombin in awake sheep.
    Perlman MB; Lo SK; Malik AB
    J Appl Physiol (1985); 1986 Feb; 60(2):546-53. PubMed ID: 3512510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of platelet aggregation with intravenous and oral administration of carboprostacyclin in man.
    Karim SM; Adaikan PG; Lau LC; Tai MY
    Prostaglandins Med; 1981 May; 6(5):521-7. PubMed ID: 7022510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of a platelet-activating factor (PAF) antagonist, SR 27417A, on PAF-induced gas exchange abnormalities in mild asthma.
    Gómez FP; Roca J; Barberà JA; Chung KF; Peinado VI; Rodriguez-Roisin R
    Eur Respir J; 1998 Apr; 11(4):835-9. PubMed ID: 9623685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous administration of prostacyclin in rabbits: elimination kinetics and blood pressure response.
    Skrinska VA; Lucas FV; Chisolm GM; Hesse BL
    J Lab Clin Med; 1986 Mar; 107(3):187-93. PubMed ID: 3512745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo interaction of prostacyclin with an inhibitor of cyclic nucleotide phosphodiesterase, HL 725.
    Darius H; Lefer AM; Leprán I; Smith JB
    Br J Pharmacol; 1985 Mar; 84(3):735-41. PubMed ID: 2985163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of inhaled lyso-platelet-activating factor on airway microvascular leakage in the guinea pig.
    Sakamoto T; Elwood W; Barnes PJ; Chung KF
    J Appl Physiol (1985); 1993 Mar; 74(3):1117-22. PubMed ID: 8482649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.